Literature DB >> 21953863

Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.

Hongliu Ding1, Alison K Sarokhan, Sarah S Roderick, Rachit Bakshi, Nancy E Maher, Paymon Ashourian, Caroline G Kan, Sunny Chang, Andrea Santarlasci, Kyleen E Swords, Bernard M Ravina, Michael T Hayes, U Shivraj Sohur, Anne-Marie Wills, Alice W Flaherty, Vivek K Unni, Albert Y Hung, Dennis J Selkoe, Michael A Schwarzschild, Michael G Schlossmacher, Lewis R Sudarsky, John H Growdon, Adrian J Ivinson, Bradley T Hyman, Clemens R Scherzer.   

Abstract

BACKGROUND: Mutations in the α-synuclein gene (SNCA) cause autosomal dominant forms of Parkinson's disease, but the substantial risk conferred by this locus to the common sporadic disease has only recently emerged from genome-wide association studies.
METHODS: We genotyped a prioritized noncoding variant in SNCA intron 4 in 344 patients with Parkinson's disease and 275 controls from the longitudinal Harvard NeuroDiscovery Center Biomarker Study.
RESULTS: The common minor allele of rs2736990 was associated with elevated disease susceptibility (odds ratio, 1.40; P = .0032).
CONCLUSIONS: This result increases confidence in the notion that in many clinically well-characterized patients, genetic variation in SNCA contributes to "sporadic" disease.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953863      PMCID: PMC3337217          DOI: 10.1002/mds.23934

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

1.  PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.

Authors:  Bin Zheng; Zhixiang Liao; Joseph J Locascio; Kristen A Lesniak; Sarah S Roderick; Marla L Watt; Aron C Eklund; Yanli Zhang-James; Peter D Kim; Michael A Hauser; Edna Grünblatt; Linda B Moran; Silvia A Mandel; Peter Riederer; Renee M Miller; Howard J Federoff; Ullrich Wüllner; Spyridon Papapetropoulos; Moussa B Youdim; Ippolita Cantuti-Castelvetri; Anne B Young; Jeffery M Vance; Richard L Davis; John C Hedreen; Charles H Adler; Thomas G Beach; Manuel B Graeber; Frank A Middleton; Jean-Christophe Rochet; Clemens R Scherzer
Journal:  Sci Transl Med       Date:  2010-10-06       Impact factor: 17.956

2.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

3.  Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.

Authors:  O Chiba-Falek; R L Nussbaum
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

4.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

Authors:  Andrew J Hughes; Susan E Daniel; Yoav Ben-Shlomo; Andrew J Lees
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

5.  Multiple regions of alpha-synuclein are associated with Parkinson's disease.

Authors:  Jakob C Mueller; Julia Fuchs; Anne Hofer; Alexander Zimprich; Peter Lichtner; Thomas Illig; Daniela Berg; Ullrich Wüllner; Thomas Meitinger; Thomas Gasser
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

6.  GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein.

Authors:  Clemens R Scherzer; Jeffrey A Grass; Zhixiang Liao; Imelda Pepivani; Bin Zheng; Aron C Eklund; Paul A Ney; Juliana Ng; Meghan McGoldrick; Brit Mollenhauer; Emery H Bresnick; Michael G Schlossmacher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

7.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

  7 in total
  15 in total

1.  Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study.

Authors:  Rachit Bakshi; Eric A Macklin; Albert Y Hung; Michael T Hayes; Bradley T Hyman; Anne-Marie Wills; Stephen N Gomperts; John H Growdon; Alberto Ascherio; Clemens R Scherzer; Michael A Schwarzschild
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 3.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

4.  Specific splice variants are associated with Parkinson's disease.

Authors:  Jose A Santiago; Clemens R Scherzer; Judith A Potashkin
Journal:  Mov Disord       Date:  2013-09-20       Impact factor: 10.338

5.  Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study.

Authors:  Hongliu Ding; Kaltra Dhima; Kaitlin C Lockhart; Joseph J Locascio; Ashley N Hoesing; Karen Duong; Ana Trisini-Lipsanopoulos; Michael T Hayes; U Shivraj Sohur; Anne-Marie Wills; Brit Mollenhauer; Alice W Flaherty; Albert Y Hung; Nicte Mejia; Vikram Khurana; Stephen N Gomperts; Dennis J Selkoe; Michael A Schwarzschild; Michael G Schlossmacher; Bradley T Hyman; Lewis R Sudarsky; John H Growdon; Clemens R Scherzer
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

6.  Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.

Authors:  Jose A Santiago; Clemens R Scherzer; Judith A Potashkin
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

7.  β-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters.

Authors:  Young Eun Huh; Ming Sum Ruby Chiang; Joseph J Locascio; Zhixiang Liao; Ganqiang Liu; Karbi Choudhury; Yuliya I Kuras; Idil Tuncali; Aleksandar Videnovic; Ann L Hunt; Michael A Schwarzschild; Albert Y Hung; Todd M Herrington; Michael T Hayes; Bradley T Hyman; Anne-Marie Wills; Stephen N Gomperts; John H Growdon; Sergio Pablo Sardi; Clemens R Scherzer
Journal:  Neurology       Date:  2020-06-15       Impact factor: 9.910

Review 8.  A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson's disease.

Authors:  Camilla Christina Pedersen; Johannes Lange; Marthe Gurine Gunnarsdatter Førland; Angus D Macleod; Guido Alves; Jodi Maple-Grødem
Journal:  NPJ Parkinsons Dis       Date:  2021-07-01

9.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

10.  Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.